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The demonstration described here is a hyperoxic rebreathing test that uses the participant's metabolically derived CO 2 as a respiratory and cerebrovascular stimulant. The resulting respiratory and cerebrovascular responses will be illustrated and subsequent analysis will be explored. The intended audience for this article comprises 1) senior undergraduate, graduate, or medical students seeking a more comprehensive understanding of integrative cardiorespiratory and cerebrovascular human physiology; 2) college or university laboratory instructors and course coordinators looking for a more advanced tutorial, practical laboratory demonstration, or case study; and/or 3) new investigators looking for the appropriate equipment and methodology required to establish the rebreathing test in their laboratories. In addition, we include methodological suggestions for simplifying the activity, helpful terminology (APPEN-DIX 1), critical thinking questions (APPENDIX 2), and relevant equations (APPENDIX 3).
In a recent issue of this journal, Domnik et al. (12) illustrated the utility of the rebreathing test as a laboratory demonstration for the central chemoreflex control of breathing. Domnik et al. performed the "Duffin" modified rebreathing test on 33 healthy young participants, described the test, and illustrated the plotting and quantification of the ventilatory recruitment threshold and the ventilatory response to CO 2 . We expand on the excellent contribution from Domnik et al. in the following ways:
1. We include descriptions and figures that illustrate the theoretical perspectives of respiratory chemoreflex control and cerebrovascular regulation (both anterior and posterior circulations).
2. We include a complete description of the methodology and protocol, the appropriate use of laboratory equipment, typical results (both raw traces and quantification), a discussion of data analysis (e.g., linear regression and R 2 values) and considerations of absolute versus normalized data.
3. We provide helpful suggestions for simplifying the test and appendixes of terminology, critical thinking questions (with answers to each questions for instructor use and adoption), and helpful mathematical equations.
4. Finally, we include references to and discussion of the relevant physiology education and clinical literature.
These two articles are excellent companion papers illustrating the rebreathing test as a laboratory demonstration for central respiratory chemosensitvity, cerebrovascular reactivity, and data analysis and to illustrate the integrative nature of the respiratory and cerebrovascular systems in the training of senior physiology and medical students.
Chemoreceptors
A chemoreceptor is any sensory cell that responds to its surrounding chemical environment in a specific way that aids directly in the homeostasis of the organism. Examples include gustatory and olfactory cells (for the sense of taste and smell, respectively), macula densa cells in the distal tubules of the nephron (filtrate Na ϩ sensing), interstitial fibroblasts in the renal cortex (oxygen sensing and erythropoietin release), central and peripheral respiratory chemoreceptors (respiratory gas sensing; see below), and vascular smooth muscle cells (respiratory gas sensing; see below). Respiratory chemoreceptors are connected to the respiratory controller within the brain stem (ventral respiratory group in the ventrolateral medulla) and respond to changes in respiratory gases (CO 2 and O 2 ), mediating ventilatory responses through two separate but interacting negative feedback loops (see Fig. 1 ). Vascular smooth muscle cells are also chemosensitive, whereby changes in respiratory gases within the vessels or in the nearby tissue can affect the contractile units, lumen diameter, vascular resistance, and blood flow (see Fig. 2 ).
Central and peripheral respiratory chemoreceptors. Blood gas homeostasis is coordinated, in part, through central and peripheral respiratory chemoreflex feedback loops (see Fig. 1 ), each with their own respective sensitivity and onset delay. Slower-acting central respiratory chemoreceptors (CCRs) are activated in response to increases in local tissue PCO 2 (17) . Faster-acting peripheral respiratory chemoreceptors (PCRs) respond synergistically to changes in both arterial PCO 2 (Pa CO 2 ) and PO 2 (Pa O 2 ). (13, 34, 43) . The dominant afferent input that maintains breathing when you are conscious is the descending "wakefulness drive" from the cerebral cortex (16) . Because blood gases stay relatively constant during wakefulness, CCRs and PCRs are not thought to 2 ) and the effectiveness of tissue washout through CBF and pulmonary ventilation (sink; decreases CO 2 ). Thus, CO 2 does not diffuse into chemoreceptors from the blood, as many textbooks state, as the gradient for CO 2 is directed out of the brain tissue and into the blood in most conditions. Accumulation of CO 2 in brain stem tissue, due to changes in metabolism, brain blood flow, and/or alveolar ventilation, stimulates CCR neurons. It is this slow accumulation in tissue that accounts for a lung-to-ventilatory response delay of the central chemoreflex of ϳ25-30 s (43). The traditional view is that CCRs dominate the ventilatory chemoresponse to CO 2 . However, PCRs also contribute to ventilatory responsiveness to inspired CO 2 , in an oxygen-dependent fashion (10, 23) .
PCRs are located bilaterally, at the bifurcation of the internal and external carotid arteries, and monitor arterial PO 2 (Pa O 2 ) and Pa CO 2 /[H ϩ ] of the blood flowing through a small carotid body artery, which branches off either the external carotid or occipital artery (13, 34) . Owing to their convenient location just off the aortic arch, the carotid bodies respond rapidly to changes in Pa O 2 and Pa CO 2 . The lung-to-ventilatory response delay of the peripheral chemoreflex has been reported to be ϳ15-20 s (43). Glomus cells within the carotid bodies respond to increases in CO 2 (hypercapnia) and decreases in O 2 (hypoxia). Hypoxia increases the sensitivity to CO 2 , whereas hyperoxia blunts the sensitivity to CO 2 (10, 23, 31) .
Central respiratory chemoreflex. It is difficult to isolate CCRs and PCRs in human participants, as both chemoreceptor compartments are affected by the arterial circulation, albeit in different ways (see above). PCRs can be isolated to some extent by steady-state hypoxia or by transient changes in blood gases (8, 14, 27, 45) . Given the synergistic nature of hypercapnia and hypoxia sensing at the carotid bodies, PO 2 levels of Ͼ300 Torr are likely adequate to silence PCRs (10, 13, 23) . In this way, hyperoxia can effectively isolate the central chemoreflex response to increases in CO 2 .
Quantifying respiratory CO 2 reactivity. During rebreathing, there will be a certain level of CO 2 above which an individual will begin to increase their minute ventilation (V I; volume of air moved in and out of the lungs per minute, in l/min). This point, known as the ventilatory recruitment threshold (VRT), is the PCO 2 required to activate CCRs (i.e., above their basal tonic activity). After the VRT, ventilation increases linearly in a CO 2 -dependent fashion (31) . The slope of the breath-by-breath ventilation above the VRT as CO 2 increases quantifies the central respiratory chemoreflex sensitivity or responsiveness. This response will be dampened to some extent by the cerebrovascular responsiveness to the same CO 2 stimulus, as the increase in CBF will effectively dampen the extent of CO 2 accumulation in the brain stem through CO 2 washout and thus CCR activation (see Integration Between the Chemoreceptor Control of Breathing and CBF below) (2).
Cerebrovascular CO 2 Reactivity
Cerebrovascular reactivity refers to the vasomotor responsiveness of intracranial blood vessels to changes in blood gas stimuli. Although the entire cerebrovasculature is sensitive to changes in blood gases, the CBF response is considered to be principally mediated at the arterioles downstream from large conduit vessels (15, 20, 52, 54, 55 Fig. 2 ). Specifically, hypoxia (reduced O 2 ) and hypercapnia (increases in CO 2 ) both elicit dilation, increasing the diameter and reducing resistance of cerebral arterioles and therefore increasing CBF (see Fig. 2 and APPENDIX 3) (4, 22, 26) . These cerebrovascular responses occur from stimulation on either the intravascular or tissue side of the vessel. Changes in arterial gases can be experimentally induced by changing inspired gas levels (e.g., hyperventilation or breath holding). Changes in tissue gases can result from a change in the arterial-brain tissue gradient or in the metabolic rate of the tissue (54) .
Quantifying cerebrovascular CO 2 reactivity. CBF can be quantified using transcranial Doppler ultrasound (TCD), where the velocity of red blood cells (CBV) can be used as an index of flow (1, 52) . During rebreathing, as CO 2 accumulates in a closed rebreathing circuit (and thus the vascular and tissue compartments), arterioles dilate, and an increase in CBV can be measured in conduit vessels using TCD (see METHODS below). Mean CBV can be plotted by sampling the PCO 2 (x-axis) and CBV (y-axis) on a breath-by-breath basis (i.e., triggered off every expired breath) or on a beat-by-beat basis (i.e., triggered off every R wave of the ECG). The slope of the CBV response as PCO 2 increases can be used to quantify cerebrovascular CO 2 reactivity (41, 53) .
Integration Between the Chemoreceptor Control of Breathing and CBF
Although the central respiratory chemoreflex and cerebrovascular CO 2 responses can be tested in isolation, these two systems are functionally linked (see Fig. 3 ). CBF dictates the washout of metabolically derived CO 2 from brain stem tissue, where the CCR neurons are located. These chemoreceptors are stimulated when CO 2 accumulates in tissue because the usual arterial-venous (a-v) gradient (6-to 8-Torr PCO 2 ) is decreased, either by changes in Pa CO 2 or changes in the metabolic rate of the tissue. Changes in CBF (cerebrovascular reactivity) can alter the activation of CCRs, as increases in CBF decreases tissue CO 2 (through increased washout) and decreases in CBF increase tissue CO 2 (through metabolic CO 2 accumulation). In this way, the cerebrovascular CO 2 reactivity can limit the extent a change in Pa CO 2 is reflected in brain tissue (2) . During rebreathing, the usual arterial-brain tissue PCO 2 gradient is abolished, which effectively uncouples the integration between the central respiratory chemoreflex and cerebrovascular reactivity (see DISCUSSION below).
Tests of the Central Respiratory Chemoreflex and Cerebrovascular Reactivity
There are two general types of respiratory tests that can be used to stimulate both respiratory chemoreflexes and cerebrovascular responses: steady state (13, 32) and rebreathing (6, 13, 35) . A steady-state method is simply a single or multistep increase in the fraction of inspired CO 2 (FI CO 2 ) or decrease in fraction of inspired O2 (FI O 2 ) to elicit a ventilatory or cerebrovascular response. Examples include 1) breathing atmospheric air at high altitudes, 2) sitting in a simulated altitude chamber, 3) breathing a specified gas mixture from a bag or mixing chamber, or 4) using an end-tidal forcing system using computer-controlled feedback of end-tidal gases (15) .
The "Read" hyperoxic rebreathing method was developed as a clinical test of the central respiratory chemoreflex (35) . In contrast to steady-state methods, this test is assumed to eliminate or reduce the usual a-v gradients within the brain, such that end-tidal PCO 2 (PET CO 2 ; an estimate of alveolar and arterial gas) approximates the level of stimulus at CCRs in brain tissue. This is accomplished by initially inspiring an elevated level of PCO 2 (typically 5-7% compared with 0.04% in room air) and rebreathing from a closed circuit. The Duffin modified rebreathing test was later developed to allow for the assessment of basal ventilation and VRT of the central chemoreflex (6, 13, 16) .
Learning Objectives
After performing the present laboratory exercise, the successful student will be able to:
1. Set up the equipment to carry out the Duffin hyperoxic rebreathing test and use the various instruments required to measure respiratory and cerebrovascular variables.
2.
Describe the role of CCRs and PCRs in the respiratory response to changes in inspired gases and draw the feedback loops for respiratory chemoreflex responses to changes in CO 2 and O 2 .
3. Predict what will happen to CBF with increases or decreases in arterial CO 2 .
4. Understand and describe how CCRs and cerebrovascular control are functionally integrated and how the rebreathing test uncouples this relationship.
5. Perform the analysis and quantification of respiratory and cerebrovascular responses to CO 2 using linear regression as well as analyze raw data, graph the respiratory and cerebrovascular responses, and perform linear regression as a measure of responsiveness.
6. Explain the methods, utility, and caveats of reporting both absolute and normalized data and give an example of how presenting data as a percent change may be misleading when comparing two different data sets with different baseline values.
7. Describe how the principles outlined in this demonstration are relevant to understanding core concepts in physiology and are relevant to clinical populations; specifically, the student will be able to describe how cerebrovascular reactivity changes with aging and may have implications for clinical sleep apnea populations.
METHODS
Both central respiratory chemosensitivity and cerebrovascular CO 2 reactivity can be demonstrated through the use of the Duffin modified hyperoxic rebreathing test. Below is an example of the instrumentation and protocol to perform the modified hyperoxic rebreathing test in a laboratory setting.
Working with Human Participants
Adopters of this activity are responsible for obtaining informed consent and ethics/permission to work with human participants at their home institution. In Canada, research activities must be cleared by a local Research Ethics Board and conform with the Tri-council Policy Statement on research ethics (TCPS2), which is consistent with the Declaration of Helsinki. For a summary of the American Physiological Society's "Guiding Principles for Research Involving Animals and Human Beings," please see www.the-aps.org/mm/ Publications/Ethical-Policies/Animal-and-Human-Research. If this activity is used as a demonstration only, written informed consent must still be obtained from participants. Sample traces and data included in this report (Figs. 5-8 and Table 1 ) were obtained in the laboratory of T. A. Day (Mount Royal University, University of Calgary Conjoint Research Ethics Board, Protocol E-23655) after written informed consent by participants.
Instrumentation
All data were collected using a 16-channel Power Lab system [Powerlab/16SP ML880, AD Instruments (ADI), Colorado Springs, CO] and analyzed offline using commercially available software (LabChart Pro software).
The rebreathing apparatus incorporates a nose clip, mouthpiece (with a luer lock gas sampling port installed), disposable bacteriological filter, respiratory flow head (ADI MLT1000L or Hans Rudolph 800L), and three-way valve to allow switching between room air and a 6-liter latex anesthetic bag (Rusch, Teleflex Medical, Markham, ON, Canada) prefilled with 93% O 2 and 7% CO 2 (see Fig. 4 ). Respiratory flow is measured through the use of the pneumotachometer (flow head and spirometer amplifier, ML141, ADI). Percent gas compositions of O 2 and CO 2 are measured breath by breath using an integrated CO 2 and O 2 gas analyzer (ML206, ADI), calibrated daily with known gas samples. End-tidal PO 2 (PET O 2 ) and PET CO 2 are calculated in Torr [body temperature and pressure, saturated (BTPS)] using the daily atmospheric pressure (see APPENDIX 1) .
Respiratory variables are derived from the respiratory flow signal. It is important that the spirometer is both "zeroed" and calibrated before beginning a trial. The ADI "spirometry module" can be used to calculate V I (in l/min) directly from the flow channel, using the average bin size you desire. A more sophisticated approach is to derive respiratory frequency (f R ) and inspired tidal volume (V TI ) separately from the respiratory flow channel and then calculate breathby-breath V I. f R can be calculated using the rate function under the cyclic measurements (60/period). V TI can be calculated using the "standard integral" on the inspired portion of the flow tracing (choose "reset after each cycle"). An additional channel can be set up that detects the peak of this volume tracing. You can then calculate V I (in l/min) by multiplying f R (in breaths/min) and peak V TI (in liters) channels together using the arithmetic function.
Bilateral TCD is performed using a 2-MHz pulsed Doppler ultrasound system (PMD150B, Spencer Technologies, Redmond, WA) to insonate and noninvasively measure the CBV of the middle cerebral arteries (MCAs; anterior circulation) and posterior cerebral arteries (PCA; posterior circulation) (52) . Mean CBV can be calculated from the envelope of the velocity tracing using LabChart analysis software using the "mean" function under "cyclic measurements." We purchased our Spencer bilateral TCD unit in June 2011 for approximately $31,000 CAD.
If you have the capability to use TCD, it is important to ensure that you are insonating the vessels you intend to. For example, you can validate your measurement by ensuring standardized probe position, direction of flow, and accepted depths and baseline velocities for the vessels of interest. There are also functional tests that can be used. For example, a transient carotid compression test (which should only be performed on healthy young individuals) on the same side as the MCA will decrease the velocity (given the anatomy of the circle of Willis), whereas the PCA will remain unchanged or increase (1, 52) . In addition, the PCA velocity will increase with a light stimulus test, given that this conduit perfuses the occipital lobe where visual processing takes place (i.e., neurovascular coupling). A more comprehensive explanation of TCD methodology is beyond the scope of this report (for a review, see Ref. 52) . If the reader is interested in training in TCD, please contact the corresponding author for more information.
Participants should be seated comfortably in semi-Fowler's position (we use a dentist chair) or placed in the supine position on a bed, although body position does not appear to affect the magnitude of the respiratory chemoreflex or cerebrovascular reactivity (42, 45) . A mouthpiece holder can be fashioned overhead using cables/cords hung from the ceiling or using a Douglas bag rack. Participants should refrain from alcohol, caffeine, strenuous exercise, or a large meal before participation. Investigators may wish to test female participants in the early follicular phase (i.e., during menses) to limit the possible effects of cycling ovarian hormones on respiratory or cerebrovascular variables. We use white noise through ear buds to minimize participant distraction. The laboratory should be kept dark, and eyes should be closed to minimize confounding effects of light stimulus on PCA responses (i.e., neurovascular coupling).
Protocol
After instrumentation, the participant should be allowed to relax for at least 5 min breathing room air, in the supine or sitting position, before the rebreathing test. They are then coached to hyperventilate (increase in both tidal volume and breathing frequency) for 5 min to reach a target PET CO 2 of ϳ20 -25 Torr (i.e., ϳ15-20 Torr below baseline). At this point, they are asked to take a full inspiration and a full expiration; the three-way valve is then switched from room air to the rebreathing circuit. The participant is then coached to take three large breaths to equilibrate with the circuit, after which the participant is asked to breathe normally from the bag (ϳ4 -6 min) until 1) the respiratory response becomes intolerable and they signal to terminate the test, 2) the PET CO 2 value reaches ϳ55 Torr, or 3) the rebreathing bag is deflated. It should be noted that, initially, participants will feel very little change in the urge to breathe and, near the end of the test, they will experience a very powerful urge to breathe, as shown in the respiratory flow tracing in Fig. 5 . Informing the participant that these are normal responses helps them prepare and reduce anxiety.
RESULTS
The following results illustrate typical responses from the Duffin hyperoxic rebreathing test, including central respiratory chemoreflex and cerebrovascular responses to increases in CO 2 , as well as descriptions of analysis. These responses will each be demonstrated with a sample data tracing (Figs. 5 and 7) and figures illustrating analysis and quantification (Figs. 6 and 8). These can serve as guides for those that wish to replicate the test and the data or these traces can be adopted for tutorial discussion.
Baseline Variables
During the initial baseline period, the participant is allowed to relax so that representative values can be obtained. It is likely that due to the anxiety of being instrumented and anticipation, ventilation will be higher than the normal textbook value of ϳ6 -8 l/min, which will make them relatively hypocapnic. It is helpful to use a long baseline (e.g., at least 5 min) and take a representative sample from late in the period. Taking an average time bin (e.g., ϳ1 min) ensures that your baseline values are truly representative, so that any value that is nonrepresentative is washed out in the average. See Table 1 for representative baseline respiratory and cerebrovascular data in Calgary, AB, Canada. Fig. 4 . Picture of the rebreathing apparatus. From proximal to distal: nose clip, mouthpiece with gas sample port installed (tubing attached to gas analyzer), disposable bacteriological filter; 1,000-liter respiratory flow head (tubing attached to spirometer amplifier), three-way valve for switching between room air and rebreathing circuit (with optional return line from exhaust of gas analyzer), and 6-liter anesthetic bag (with filling port at distal end).
Central Respiratory Chemosensitivity Figure 5 shows a raw data tracing from the hyperoxic rebreathing test illustrating the respiratory responses during the rebreathing protocol. Figure 6 shows the analysis and quantification of the respiratory response to CO 2 during rebreathing. Breath-by-breath analysis of V I (the product of f R and V TI ) for a given PET CO 2 can be plotted using a spreadsheet program (e.g., Microsoft Office Excel) or other graphing software. Specifically, for the analysis performed here, Microsoft Excel scatterplots of breath-by-breath data were created. As shown in Fig. 6 , there is an initial period of steady V I followed by an inflection point (VRT), which is the level of CO 2 above which ventilation departs from basal ventilation and increases linearly (6, 13) . Past the VRT, linear regression is used to determine the slope of the response (i.e., the sensitivity or responsiveness). The VRT can be estimated subjectively by eye [e.g., having two or more investigators determine the inflection point visually and average the value (42)] or analysis software can be used to detect it more objectively (56) . Figure 7 shows a raw data tracing from the hyperoxic rebreathing test illustrating the cerebrovascular responses during the rebreathing protocol. Figure 8 shows the analysis and quantification of the cerebrovascular response to CO 2 during rebreathing. The breath-by-breath analysis of mean CBV for a given inspired CO 2 can be plotted using a spreadsheet program or other graphing software. Linear regression can be used to determine the slope of the CBV response to CO 2 (i.e., the cerebrovascular reactivity). Alternatively, you could sample CBV during every cardiac cycle using the R wave of an ECG signal. For simplicity, we are not including cardiovascular variables (e.g., heart rate and blood pressure) in this report (see Methodological Considerations below) (5, 33, 41) .
Cerebrovascular CO 2 Reactivity

DISCUSSION
In the present report, we have outlined a laboratory exercise that has the utility of demonstrating central respiratory chemosensitivity, cerebrovascular CO 2 reactivity, and the integration between the two systems. While these responses can be demonstrated and analyzed separately, they are functionally related to one another. Using the Duffin hyperoxic rebreathing test, central respiratory chemosensitivity and cerebrovascular responses in both anterior and posterior circulations can be measured, and common methods of data analysis in physiology can be illustrated. ), which quantifies the sensitivity (responsiveness) of the individual's central chemoreflex (see Fig. 6 ).
Cerebrovascular CO 2 Reactivity
Smooth muscle cells of the cerebral vasculature (primarily arterioles) respond to changes in arterial or local tissue gas levels, eliciting a cerebrovascular response (i.e., change in CBV; see Figs. 2 and 3) , which can be measured using TCD. TCD measures the velocity (in cm/s) of blood within the cerebral vessel as opposed to volumetric flow (in ml/min). However, CBV approximates flow if the diameter of the conduit vessel being measured remains constant and only the downstream arterioles dilate. This assumption likely holds true for a narrow physiological range of blood gas changes (39, 48, 53) but may underestimate flow responses if the conduit vessel also dilates (3, 8, 53) . The hyperoxic rebreathing test can illustrate the CBV responses to both hypocapnia (during hyperventilation) and hypercapnia (during rebreathing; see Fig.  7 ). During the rebreathing test, CBV increases linearly with increases in metabolically derived CO 2 , which is measured at the mouth. Linear regression can be performed to calculate the slope of the response (⌬CBV/⌬PCO 2 ; in cm·s Ϫ1 ·Torr Ϫ1 ), which quantifies the sensitivity (responsiveness) of the individual's cerebrovascular reactivity (see Fig. 8 ). Linear regression of CBV responses can also be performed in the hypocapnic range if hyperventilation is performed in a number of graded steps of relative increases in ventilation (53) .
We compared two large intracranial conduit vessels: the MCA and PCA. The MCA has been previously shown to have a larger absolute response to increases in CO 2 during rebreathing compared with the PCA (38, 41) . However, this difference Values are means Ϯ SD. Note that minute ventilation is higher and end-tidal PO 2 is lower than textbook values. These differences are likely 1) because of the typical hyperventilation noted when human participants are instrumented for respiratory measurements and 2) because these data were collected in Calgary, AB, Canada, ϳ1,100 m above sea level, where a mild hypocapnia results from a mild and sustained hypoxic ventilatory response. BTPS, body temperature and pressure, saturated. is absent when CBV values during rebreathing are normalized to baseline values, as shown in Fig. 8 . These different conclusions can be explained by comparing their baseline values; the MCA has a higher baseline values than that of the PCA (see Table 1 and Fig. 8) (51) . This illustration demonstrates an important consideration in the presentation of physiological data, as different conclusions may be drawn depending on whether absolute or normalized data are presented (see Analysis Considerations below).
Integration Between CCRs and Brain Blood Flow
The central respiratory chemoreflex and cerebrovascular regulation are intricately linked (2), as cerebrovascular reactivity to increases in CO 2 serves to washout brain stem CO 2 and hence keep central PCO 2 /[H ϩ ] constant (see Fig. 3 ). Although the hyperoxic rebreathing test can elicit both central respiratory chemoreflex and cerebrovascular responses, it effectively uncouples the normal relationship that exists between the two systems (i.e., opens up the feedback loop). The reason for this uncoupling is that the rebreathing test breaks down the usual arterial-brain tissue PCO 2 gradient and removes the influence of cerebrovascular reactivity on chemoreflex responsiveness. As shown in Figs. 5 and 7, the fluctuations in PCO 2 that are normally present between inspiration and expiration when breathing room air are minimized or absent during rebreathing.
Normally, when cerebral metabolism increases, local tissue PCO 2 rises, dilating cerebral arterioles, increasing washout from brain stem tissue, maintaining tissue PCO 2 /[H ϩ ] and chemoreceptor activation at a minimum (see Fig. 3 ). Those individuals with higher CBF responses will have reduced chemoreceptor activation, whereas those with reduced CBF responses will have enhanced chemoreceptor activation (2, 15) . These effects are independent of the intrinsic respiratory chemosensitivity of the individual.
Consider the case of a steady-state respiratory test, where the usual arterial-brain tissue gradients are maintained. Experimentally induced increases in Pa CO 2 also increase CBF (i.e., increased washout), which will ensure that the increases in Pa CO 2 are minimally reflected in the brain stem tissue, where CCRs reside (see Fig. 3 ). However, when a rebreathing test is used, the source of CO 2 is the brain metabolic rate of the tissue itself, and the arterial-brain tissue gradient is abolished by the test. CO 2 -induced changes in CBF have no effect on the washout of CO 2 from brain stem tissue. Thus, the cerebrovas- Note that although the two vessels appear to have similar reactivity magnitudes, the y-axis scales are different. The O 2 channel verifies that hyperoxia was maintained throughout the rebreathing period.
cular CO 2 response has no bearing on the central chemoreflex response, and the inherent responsiveness of both systems can be obtained.
Methodological Considerations
There are a number of modifications that can be made to the rebreathing test to simplify or expand this laboratory demonstration.
1. Simplify the rebreathing test. Depending on the equipment you have available, using a rebreathing bag initially filled with medical grade 95% O 2 and 5% CO 2 (readily available in most biology or medical departments) and recording respiratory flow is a simple laboratory demonstration of the central respiratory chemoreflex. To simply the test further, a participant can simply fill a large rebreathing bag with expired gases from a maximal inspiration and begin rebreathing until a respiratory response is noticeable. Care must be taken to ensure that the test is terminated before PET O 2 and O 2 saturation drop below reasonable safety cutoffs (e.g., 45 Torr and 70%, respectively).
2. Use a plastic shopping bag. If you do not have access to a 6-liter anesthetic bag, you can use a 6-to 8-liter plastic vegetable shopping bag, the type you get at the supermarket. The benefits are that these are disposable and bigger, allowing you to increase the range of CO 2 stimulus. The bigger the bag, the longer the test can last, but the longer it takes to reach a target level of hypercapnia.
3. Shorten the prior hyperventilation duration. Having a participant voluntarily hyperventilate for 5 min can be uncomfortable, as they may experience dizziness. Although it is assumed that a full 5 min is required to clear the body CO 2 stores, there is no experimental evidence for this assumption. In a recent publication, we used 1-min prior hyperventilation duration, and the results appeared to be representative of other studies (41, 42, 47) . Alternatively, the rebreathing test can be performed without any prior hyperventilation (the Read rebreathing test) (35) . This is adequate to demonstrate increases in ventilation or CBF during rebreathing.
4. Return the exhaust from the gas analyzer to extend the length of the test. One of the reasons the bag will eventually deflate during rebreathing is that the gas analyzer is taking a sample from the circuit. The ADI ML206 gas analyzer samples up to 250 ml/min, which will shorten the length of the test, and you may not get to the desired PCO 2 level. You can return the exhaust from the gas analyzer back to the rebreathing circuit, which will extend the time of the rebreathing test, if desired.
5. Add cardiovascular variables to your test. An ECG (e.g., lead II configuration) can allow you to calculate instantaneous heart rate using the R-R interval (60/period). Additionally, if you have access to noninvasive finger photoplethysmography (e.g., Finometer Pro, Finapres Medical Systems, Amsterdam, The Netherlands), you can monitor beat-by-beat blood pressure during the rebreathing protocol. Mean arterial pressure (MAP) can then be calculated from the mean of the pressure envelope in LabChart ("mean" calculation under "cyclic measurements"). Alternatively, manual blood pressure can be obtained through the use of a sphygmomanometer and auscultation every minute during rebreathing. Increases in PCO 2 elicit increases in sympathetic activation, which will increase heart rate and MAP during rebreathing (4, 5) , representing an additional demonstration in a teaching laboratory setting. We purchased our Finapres Finometer Pro unit in June 2011 for approximately $40,000 CAD. See APPENDIX 3 for a mathematic description of the effects of cardiovascular variables on CBF.
6. Use peripheral ultrasound. If you do not have access to a TCD, a peripheral ultrasound machine can be used to measure the volumetric flow of the internal carotid and vertebral arteries that supply blood to the brain via the circle of Willis (53 Alternatively, the common carotid artery is more easily found and insonated. However, as it supplies both the internal and external carotid artery blood flow, it will overestimate the CBF response.
There are other considerations that may motivate investigators to use peripheral ultrasound, where possible. TCD measures velocity (in cm/s), which is only an index of flow (in ml/min) if the diameter of the measured conduit vessel remains constant and only downstream arterioles are dilating (52) . Although some studies have suggested that this assumption is valid within a narrow range (39, 48) , other studies have suggested that intracranial vessels may dilate across a narrow range of CO 2 (8) or at more extreme values of O 2 and CO 2 (53) . This emerging evidence suggests that measures of velocity may underestimate flow during more extreme CO 2 challenges (3). However, TCD allows for stable, continuous measures of intracranial vessels, so this technique still has utility.
Analysis Considerations
One of the most important considerations when analyzing and quantifying physiological responses is whether to present absolute or normalized values. This problem can be clearly illustrated in the cerebrovascular responses measured in the MCA and PCA to increases in CO 2 .
First, consider two participants with different responses measured in the PCA to a single steady-state step increase in CO 2 (for example, switching between breathing room air to inspiring 2% CO 2 ): If the PCA velocity in participant 1 increases from 30 to 40 cm/s and that of participant 2 increases from 40 to 50 cm/s, you can see that both increase by the same absolute amount: 10 cm/s. However, because the participants had different baseline velocities, if we were to express their response as a percent change from baseline, we would arrive at different conclusions: participant 1 increased 33%, whereas participant 2 only increased 25%. Now, note the response slope of the MCA and PCA during rebreathing (Fig. 8) . The MCA has a larger absolute (i.e., raw data) response to increases in CO 2 than the PCA. The slope of the response is almost twofold higher in the MCA. However, the MCA has a higher starting velocity than the PCA (see Table 1 and Fig. 8 ), so when each measurement is normalized to the baseline value, the responses appear the same.
It is common to present normalized data in physiology, as a percent change is a convenient representation that is easy to grasp (e.g., "The participant's heart rate increased by 50%"). However, when comparing a variable between two individuals or comparing two different measurements within an individual, note that different starting points (i.e., baseline) will be reflected if data are presented in a normalized (i.e., percent change) fashion. It is unclear which is the most appropriate method of data presentation. The answer lies in the question being asked, and if in doubt, both absolute and normalized data should be reported.
Utility in Health Science Education and Clinical Applications
In the health science education setting, the hyperoxic rebreathing test is relatively simple to set up and perform and is a safe test to quantify both respiratory and cerebrovascular responses to increases in CO 2 in healthy or clinical populations. This test has been previous adopted for an educational demonstration, which focused only on the control of breathing (12) . The hyperoxic rebreathing test also has theoretical utility, where advanced students of physiology or medicine require an understanding of fundamental principles of respiratory, cardiovascular, and cerebrovascular control but also an understanding of the integration between multiple organ systems in health and disease. These topics also lend themselves toward integration and application of basic principles such as homeostasis (e.g., responses to stressors), control systems and feedback loops (e.g., respiratory chemoreflexes), driving forces (e.g., respiratory gas gradients), and relationships between structure and function (e.g., proximity of cerebral blood vessels to central chemoreceptors), all core concepts that have been identified in the physiology education literature (28 -30) . In addition to the practical and theoretical elements of the rebreathing test, collecting, analyzing, and interpreting data, both for graphical and statistical presentation, are important skills to develop in students of physiology and medicine.
The rebreathing test also has utility in 1) research settings, where quantification of these responses is required (41, 42, 47) , and 2) healthcare settings, where clinical populations have alterations in respiratory and/or cerebrovascular control. For example, respiratory chemoreflex sensitivity is relevant to conditions such as sleep apnea, where high sensitivity of the respiratory chemoreflexes can lead to respiratory instability during sleep, particularly in the setting of congestive heart failure (44, 46) . In addition, baseline CBF and cerebrovascular reactivity is altered with aging (57), which can also lead to or exacerbate respiratory instability due to changes in brain stem CO 2 washout and central chemoreflex activation (19, 50) . In addition, reduced cerebrovascular reactivity has been linked to risk of stroke or other cerebrovascular events (21, 25, 36, 40) .
Using this Laboratory Exercise with Undergraduate Students
The reader may be interested to know the educational context in which we use this laboratory activity. We use a simple rebreathing test to illustrate respiratory chemoreflexes in a third-year, full-year "Human Physiology" course for Bachelor of Science Health Science majors in the Department of Biology at Mount Royal University. The specific exercise outlined in this report (including respiratory, cardiovascular, and cerebrovascular measures) is taught in a fourth-year "Applied Human Physiology" course. Many undergraduate students of Mount Royal University have gone on to use these techniques to collect data for studies that have subsequently been published (41, 42, 47) . Interestingly, a number of coauthors on this report were also undergraduate students when the initial work for this report was completed (C. M. MacKay, R. J. Skow, M. M. Tymko, L. M. Boulet, and C. C. M. Lemieux). flex and cerebrovascular responses to a CO 2 stimulus. Both the respiratory and cerebrovascular responses can be analyzed and quantified in isolation. However, the two systems make up an integrative feedback loop, whereby cerebrovascular reactivity can affect the magnitude of the resulting respiratory chemoreceptor activation. The rebreathing test uncouples these two systems and can illustrate the intrinsic sensitivity of the individual to increases in Pa CO 2 . Descriptions of equipment and protocol were included, and considerations of data analysis and quantification were illustrated.
APPENDIX 1: TERMINOLOGY
The following terms and definitions are presented in alphabetical order.
Absolute data: Measuring real numbers, both during baseline and during responses to a stimulus. These values can be used when presenting graphs or performing linear regression.
BTPS: Body temperature and pressure, saturated. The gas reading from a gas analyzer (which is the temperature of room air) (in %) is expressed relative to what the gas pressure would have been in the trachea. This takes into account the atmospheric pressure and water vapor pressure at body temperature (37°C). Atmospheric pressure is 760 Torr at sea level (on average), and water vapor pressure is 47 Torr at 37°C. For example, if a PET CO 2 measurement is 5.6%, the calculation to Torr (BTPS) is as follows: (760-47) ϫ (0.056) ϭ 40 Torr CO 2 .
CBF: Cerebral blood flow (in ml/min). The perfusion of the brain or specific brain regions. Global CBF can be 500 -600 ml/min at rest or ϳ15-20% of cardiac output.
CBV: Cerebral blood velocity (in cm/s). An index of CBF, assuming the diameter of the conduit artery under measurement remains constant.
CCR: Central respiratory chemoreceptor. Respiratory chemoreceptor neurons within and throughout brain stem tissue. Detect changes in tissue CO 2 /[H ϩ ]. Increases in tissue CO 2 stimulate CCRs, which affect the respiratory rhythm and pattern generator within the ventral respiratory group to increase ventilation.
Cerebrovascular reactivity: The smooth muscle responsiveness of the cerebrovasculature (primarily arterioles) to changes in arterial or tissue CO 2 and O 2 . Local hypercapnia and hypoxia both have dilatory influences, reducing resistance and increasing flow. Hypocapnia and hyperoxia (to a much lesser extent) cause vasoconstriction.
Cerebrovasculature: Conduit arteries, arterioles, and capillaries perfusing the brain.
CO 2 a-v gradient: the arterial-venous gradient. The gradient between the arterial and venous CO 2 levels, which is ϳ6-to 8-Torr CO 2 . For our purposes of brain CO 2 and central chemoreceptor stimulation, it's more helpful to think in terms of arterial-brain tissue PCO 2 gradients.
CVR: Cerebrovascular resistance. The resistance of cerebral vessels, dictated by the diameter of the vessel lumen. Diameter can be affected by changes in arteriolar or surrounding tissue CO 2 and O 2 .
Dependent variable: The responding variable that is measured, typically placed on the y-axis. Ventilation or cerebral blood velocity are examples relevant to our focus here.
Eupnea: Normal resting ventilation, matching metabolic demands. Blood gases are normal for your environment.
Hypercapnia: Higher than normal levels of Pa CO 2 . Can be caused by increases in the FI CO 2 or through hypoventilation.
Hyperoxia: Increases in Pa O 2 above normal levels, which can be caused by increases in FI O 2 or, to a lesser extent, hyperventilation.
Hyperpnea: Increases in ventilation that are appropriate to match metabolic demands.
Hyperventilation: Increases in ventilation that are in excess of metabolic demands.
Hypocapnia: Lower than normal levels of Pa CO 2 . Can be caused by hyperventilation.
Hypoventilation: Ventilation that insufficient to meet metabolic demands.
Hypoxia: Decreases in Pa O 2 below normal levels, which can be caused by reductions in FI O 2 .
Independent variable: The variable that is controlled experimentally, typically placed on the x-axis. Changes in CO 2 are an example relevant to our focus here.
Linear regression: Using a linear function to fit to a data set in a scatterplot. The formula for a linear function is y ϭ mx ϩ b, where y is the y value, x is the x value, m is the slope, and b is the y-intercept. For physiological variables, the slope (⌬y/⌬x) quantifies the responsiveness of the variable (y) to a stimulus (x). This is often performed to measure the slope (i.e., responsiveness or sensitivity) of a response. The slope represents the change in the y parameter for a given change in the x parameter. This type of analysis can be performed easily using a scatterplot in Microsoft Excel.
MCA: Middle cerebral artery. Bilateral conduit arteries arising from the circle of Willis, primarily fed by the internal carotid arteries. Together, they perfuse 70 -80% of the cerebral cortex.
mmHg: Millimeters of mercury. A measure of fluid pressure.
Normalized data: Taking measurements during a response and expressing them as a percent change from baseline. This calculation can be performed by taking the value at a specific point and subtracting the baseline value from it. Next, divide by the baseline value and multiply by 100. Sample calculation: heart rate increased from 70 to 105 beats/min, a 50% increase (105-70 ϭ 35; 35/70 ϫ 100 ϭ 50%).
Normocapnia The coefficient of determination using linear regression analysis. It represents the proportion of the variance in the dependent variable that is predictable from the independent variable (i.e., the proportion of total variation explained by a regression model) (9) . The closer the value to 1, the better the fit of the function to the data. The closer the value to 0, the less the function describes the data. This type of analysis can be performed easily using a scatterplot in Microsoft Excel.
TCD: Transcranial Doppler ultrasound. An ultrasound probe is positioned at various locations on the head and a 2-MHz pulsed wave is used to measure the cerebral blood velocity in various conduit vessels arising from the circle of Willis (e.g., MCA or PCA).
Torr: A measure of gas pressure. Approximately equal to mmHg, but respiratory physiologists in North America typically use Torr. The advantage of using Torr is that gas pressure can be differentiated from fluid pressure (e.g., blood pressure), where mmHg is used.
VRT: Ventilatory recruitment threshold. Level of CO 2 after which a person will begin to increase their minute ventilation via activation of respiratory chemoreceptors.
APPENDIX 2: CRITICAL THINKING QUESTIONS FOR DISCUSSION
The following are a list of critical thinking questions and answers that can be adopted for discussion in a classroom, tutorial, or laboratory setting. Example answers are provided.
Question 1.
Explain what it means for a feedback loop to be opened.
ANSWER. A feedback loop is composed of a sensor (which detects changes in a vital parameter), an integrating center (usually the central nervous system; which compares the measurement of the parameter with a "set point" and creates an "error signal"), and an effector (which mounts a response). In a negative feedback loop, the response returns the measured parameter toward baseline levels ("negating" the initial stimulus). When the feedback loop is closed, the response is coupled to the initial stimulus, in that the response affects the initial parameter and removes the stimulus.
When a feedback loop is opened (e.g., surgically, pharmacologically, or experimentally), the response is "uncoupled" from the stimulus. Here, the rebreathing test opens the central chemoreflex loop, as the ventilatory response has no bearing on correcting the blood gas stimulus during the test. Similarly, given that the usual a-v gradients are eliminated during rebreathing, the usual coupling between the cerebrovascular reactivity and central chemoreceptor activation is broken, and this feedback loop can also said to be opened (see Fig. 3 and question 6 below).
Question 2. Anxiety-induced hyperventilation can lead to dizziness, exacerbating the anxiety and hyperventilation. Subjects can rebreathe from a paper bag to break the positive feedback loop. What is the consequence to hyperventilation and how does of rebreathing into a paper bag counter it?
ANSWER. Hyperventilation, by definition (see APPENDIX 1), causes hypocapnia. As shown in Fig. 7 , hyperventilation-induced hypocapnia reduces brain blood flow through arteriolar vasoconstriction. This reduction in flow reduces substrate delivery (ischemia) can cause sensations of dizziness, which can exacerbate feelings of anxiety and act in a positive feedback loop to increase hyperventilation. Rebreathing into a paper bag breaks this positive feedback loop by increasing Pa CO 2 , dilating cerebral vessels (see Fig. 7 ) and relieving the cerebral ischemia and sensations of dizziness.
Question 3.
What is the significance of using a background of hyperoxia during the Duffin rebreathing test?
ANSWER. The hyperoxia (ϳ600-Torr PO 2 ) used in the Duffin rebreathing test has two distinct purposes. First, the high O 2 helps to maintain safety. As metabolically derived CO 2 is added to the bag, metabolism also uses the O 2 from the bag. In the absence of adding O 2 to the circuit, the relative hyperoxia helps to ensure that O 2 levels are maintained well above safe levels. Second, the high O 2 silences peripheral chemoreceptors, isolating central chemoreceptors with the test. Peripheral chemoreceptors detect changes in CO 2 in an O 2 -dependent fashion. PO 2 levels of Ͼ300 Torr are thought to silence peripheral chemoreceptors, even when Pa CO 2 levels are increasing.
Question 4.
Assuming the rebreathing circuit is a closed circuit, why does the 6-liter anesthetic bag eventually flatten over the duration of the rebreathing test (4 -6 min)?
ANSWER. As explained in METHODS, the gas analyzer continually samples at a rate of 250 ml/min. This would deplete the 6-liter bag in 24 min. As explained in the DISCUSSION (under Methodological Considerations), you can return the exhaust from the gas analyzer back into the circuit during rebreathing to increase the duration of the test. Even when doing this, the 6-liter bag will still be depleted over the 4-to 6-min test. At first glance, this seems a technical mystery. However, there is a physiological explanation for this. The answer lies in the respiratory exchange ratio. The respiratory exchange ratio is calculated as V CO 2 /V O 2 , where V CO 2 is the volume of CO 2 expired and V O 2 is the minute volume of O 2 consumed (per unit time). The respiratory exchange ratio can be used as a method to determine the type of fuel being used during metabolism (e.g., carbohydrates, proteins, or lipids). Because a mix of fuels is being used at rest, the respiratory exchange ratio is usually in the 0.8 range, which means that the amount of CO 2 expired is less than the amount of O 2 consumed. The fact that ϳ20% of the gas volume of each inspired breath is not returned to the bag partly explains the depletion of the rebreathing bag during the test.
Question 5.
What is a normal arterial-brain tissue (or a-v) gradient for PCO 2 ? How does the rebreathing test break down the usual gradients? What is the evidence that a-v gradients are abolished or reduced?
ANSWER. The oxygen cascade illustrates the path of atmospheric oxygen (source) to the mitochondria (sink), where oxidative metabolism uses it for ATP production. A similar cascade exits, albeit in the opposite direction, for metabolically derived CO 2 . CO 2 is created in the cell (source) and eliminated to the atmosphere (sink) through blood flow (tissue washout), transport in blood (dissolved in plasma, bound to hemoglobin and as bicarbonate), and pulmonary ventilation. Because CO 2 is always being produced in tissue through metabolic processes, CO 2 is higher in tissue (ϳ46 Torr) than arterial blood (ϳ40 Torr), which is defined as blood that has equilibrated with the alveoli. Venous blood (which is defined as blood that has equilibrated with the tissue) reflects tissue levels of CO 2 . Thus, there is a normal a-v (or arterial-brain tissue) gradient of ϳ6 -8 Torr.
The rebreathing test eliminates gradients first by reducing tissue stores through voluntary hyperventilation and then by equilibrating with the rebreathing circuit through a few deep breaths from the bag. As rebreathing continues, the rebreathing circuit, alveoli, arterial blood, tissue, and venous blood remain at similar values, as CO 2 accumulates in the circuit because metabolically derived CO 2 is moved to the bag and inspired again. Of course, there will always be a small gradient as CO 2 is created in tissue. The evidence that the global a-v gradient is largely eliminated is found on PET CO 2 measurement on the rebreathing tracing (see Figs. 5 and 7) , where there is little or no fluctuations between end-tidal and end-inspired CO 2 .
Question 6. How does the rebreathing test uncouple the usual integration between central respiratory chemosensitivity and cerebrovascular CO 2 reactivity?
ANSWER. The level of activation of CCRs is dependent on the cerebral metabolic rate (CO 2 source), the a-v gradient across the brain, and brain blood flow (washout), which is also CO 2 dependent. The cerebrovascular reactivity to CO 2 can effectively dampen the extent to which changes in arterial CO 2 are reflected in the brain through dilation and increased CO 2 washout. This washout is dependent on an intact arterial-brain tissue gradient, which is eliminated with the rebreathing test. Thus, during rebreathing, the cerebrovascular response has no bearing on brain stem tissue CO 2 , and CCRs are stimulated as metabolic CO 2 accumulates in all compartments equally.
Question 7. What is linear regression and what does it quantify?
What is an R 2 value?
ANSWER. Linear regression is a mathematical tool used to fit a linear function to a set of data plotted on an x-y graph. It is used to quantify the slope and y-intercept of any line given an x value and a y value. The R 2 value represents the coefficient of variation of the linear function to the data set, with a high R 2 value representing that the data are highly linear and a low R 2 value representing that the data are not linear. Both respiratory and cerebrovascular responses are generally linear in humans, at least within a narrow or physiological range, allowing this technique to be used to quantify the slope and thus the responsiveness (sensitivity) of these responses to CO 2 .
Question 8.
What are the strengths and weaknesses of reporting absolute data versus normalized data?
ANSWER. Presenting normalized data (i.e., percent change) is a convenient and intuitive way to express a change in any variable when a response to a stressor is introduced. However, the initial baseline value is critically important when deciding to express a response in absolute (i.e., raw numbers) or normalized terms (51) . If you want to compare data between two examples, and the baseline value is different in both cases, then the different baseline values are reflected in the expression as a percent change. Expressing data in absolute values does not suffer from this limitation, as a response in real numbers can be plotted and visualized. However, if you want to compare different responses that were measured with different units (e.g., cm/s vs. ml/min) or if a measurement has arbitrary (and thus physiologically meaningless) units (e.g., mV), a percent change allows these comparisons to be made. ANSWER. The respiratory control and cerebrovascular systems are functionally linked. A reduction in cerebrovascular CO 2 reactivity will increase the central respiratory chemoreflex response to an increase in arterial CO 2 , as this change will be reflected in brain tissue to a larger extent. Increases in chemoreflex sensitivity for any reason predispose an individual to respiratory instability, particularly during sleep. This kind of "central apnea" is prevalent in congestive heart failure patients that have high chemoreflex sensitivity. In addition, older populations have reduced basal CBF, altered CO 2 cerebrovascular reactivity, and a higher incidence of sleep apnea. Measuring respiratory chemoreflex sensitivity and cerebrovascular reactivity in these populations can have predictive or diagnostic value.
APPENDIX 3: EQUATIONS
Respiratory Equations
The amount of air inspired with each breath is the V TI (in liters). The number of times an individual breathes per minute is the f R (breaths/min). Alterations in one or both V TI and f R can alter V I (the amount of air moved in and out of the lungs each minute; in l/min), as follows:
Cerebrovascular Equations
An equation with utility in describing the regulation of CBF in response to stimuli can be derived from Ohm's law. Ohm's law states that within a conductor, the potential charge difference (V; in V) is directly related to the current flux (I) and resistance of the medium (R), as follows:
While Ohm's law refers to electricity, we can use similar principles to describe the axial flow (F) of a liquid medium through a tube via a change in axial pressure (P; driving force) and inverse to the resistance (R; lumen radius), as follows:
The axial driving force for blood throughout the entire cardiovascular system is defined as MAP. The flow of blood from the heart is cardiac output. Resistance within a blood vessel is dependent on the diameter of that vessel (and viscosity, assumed to be constant). With regard to the complex branching nature of the cardiovascular system, equation 2 can be expanded to relate MAP to cardiac output (Q) and systemic vascular resistance (SVR), as follows:
When focusing specifically on the cerebral circulation, the flow of interest is CBF. Therefore, CBF can be substituted for cardiac output. The equation can be rearranged to isolate CBF, where CBF is directly related to MAP (driving force) and inversely related to cerebrovascular resistance (CVR), which is dictated by the diameter of the cerebrovasculature. To be more precise, cerebral perfusion pressure (which is defined as MAP minus intracranial pressure) is the actual driving force for brain blood flow. However, under normal conditions where intracranial pressure is constant, MAP is an adequate approximation, as follows:
When changes in MAP occur, the mechanism that regulates CBF to maintain constant flow through alterations in CVR is termed cerebral autoregulation (24, 54) . Changes in CBF from alterations in CVR via CO 2 -dependent changes in diameter has been called cerebrovascular resistance reactivity (41, 47, 53) , as follows:
CVR ϭ MAP/CBF (6) 
